Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.23736/S2724-5691.21.08761-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Axillary surgery de-escalation for breast cancer in the era of precision medicine.
Cancer Biol Med
September 2025
Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
Management of Isolated Axillary Recurrence in Breast Cancer: Is There a Role for Targeted Axillary Dissection?
Cureus
July 2025
Surgical Oncology, Johns Hopkins University School of Medicine, Baltimore, USA.
Background The most optimal surgical strategy for ipsilateral isolated axillary recurrence (AR) in breast cancer is unknown. Axillary lymph node dissection (ALND) has historically been implemented; however, there may be an evolving role for targeted axillary dissection (TAD). Methods A retrospective analysis was conducted on patients with invasive breast cancer, followed by AR.
View Article and Find Full Text PDFBridging Global Disparities in Breast Cancer Care: External Validation Study of the MD Anderson "Nomogram To Predict Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy" and Its Financial Implications of Axillary De-escalation in a Resource Limited Setting.
Inquiry
August 2025
Shaukat Khanum Memorial Cancer Hospital and Research Center, FACS, Lahore, Punjab, Pakistan.
Axillary surgery in breast cancer has evolved from radical dissections to selective de-escalations. Identifying patients who may safely omit sentinel lymph node biopsy (SLNB) can further reduce the surgical burden, post operative complications and financial toxicity associated with breast cancer surgical care. The MD Anderson "Nomogram To Predict Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy" is widely available and free of charge to assess SLNB positivity post neoadjuvant chemotherapy (NACT).
View Article and Find Full Text PDFDoes De-Escalation of Axillary Surgery Impact Surgical Trainee Experience? A 15-Year Institutional Analysis of General Surgery Resident and Breast Surgical Oncology Fellow Operative Volumes.
J Surg Educ
August 2025
Division of Breast & Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN. Electronic address:
Objective: To assess the impact of axillary surgery de-escalation trends on general surgery resident and breast surgical oncology fellow exposure to axillary lymph node dissection cases.
Design: Accreditation Council for Graduate Medical Education case logs were retrospectively analyzed with attention to change over time. Trends in axillary lymph node dissection were evaluated using univariate linear regression.
Factors Associated With Residual Positive Lymph Nodes With Targeted Axillary Lymph Node Dissection for Breast Cancer and Accuracy of Clipped Node Retrieval in Non-Mapping Patients.
J Surg Oncol
August 2025
Department of Surgery, Los Angeles General Medical Center, Los Angeles, California, USA.
Background: The current study aimed to determine whether results could justify whether axillary lymph node dissection (ALND) could be further de-escalated in selected patients having neoadjuvant chemotherapy (NAC).
Methods: Retrospective analyses were performed for breast cancer patients treated with NAC from 2015 to 2023. Abnormal axillary nodes evaluated by pretreatment ultrasound had core biopsies with microclip placement.